Evidence | Articles | Posters
Organoids and spheroids can be grown in CellO-M*, labeled by using CellO-IF*, and imaged while still in CellO-M*.
*patent pending technology
Cell and data loss reduces the reproducibility of studies and hampers drug discovery, optimization of the drug formulation, and evaluation of in vitro disease models.
of researchers have tried & failed to reproduce other scientists’ experiments.
of researchers have failed in attempts to reproduce their own experiments.
Up to 20%
of cells can be damaged and up to 30% of the data can be lost while processing vulnerable cells
¹ Baker, M. 1,500 scientists lift the lid on reproducibility. Nature 533, 452–454 (2016); Hirsch C. and Schildknecht S. In Vitro Research Reproducibility: Keeping Up High Standards. Frontiers in Pharmacology, 10, Article 1484 (2019).
We are here to revolutionize in vitro cell culture routines, to improve cell quality, and to minimize data loss to accelerate your research.
Our patent-pending solution is a simple and elegant multi-purpose cell culture device for processing your cells in a uniquely designed environment.
We also formulate the culture media, design the extracellular matrix, create multiple immuno-labeling kits and develop cell culture devices for your experiments.
The “reproducibility crisis” was documented in this survey by Nature. Scientists need more robust experimental methods.
"Is there a reproducibity crisis?"
by Monya Baker in Nature
Cellorama’s products improve reproducibility by protecting cells during lab procedures. Read why this matters here.
“In Vitro Reproducibility: Keeping Up High Standards” by C. Hirsch and S. Schildknecht in Frontiers in Phamacology
Cellorama’s technologies facilitate 3D cell culture experiments. Read here about the increasing importance of 3D.
“Is It Time to Start Transitioning From 2D to 3D Cell Culture?” by C. Jensen and Y. Teng in Frontiers in Pharmacology